Business Context and Reporting Period
This Form 8-K is a current report filed by Integrity Applications, Inc. (not Glucotrack, Inc.) on October 7, 2016, regarding events occurring on September 30, 2016. The filing details the sixth closing of a private placement offering of Series C Convertible Preferred Stock and associated warrants to accredited investors.
Key Financial Metrics
- Gross Proceeds: $357,750 received from the sale of 357.75 Units.
- Securities Issued: 357.75 Units, each comprising one share of Series C Preferred Stock and two warrants (Series C-1 and Series C-2).
- Conversion Potential: The Preferred Stock is convertible into an aggregate of 79,500 shares of Common Stock.
- Warrant Potential: The Warrants are exercisable for an aggregate of 159,000 shares of Common Stock.
- Placement Agent Compensation: 13% of the aggregate sales price (10% commission + 3% expense allowance) plus warrants to purchase 23,850 shares of Common Stock.
Material Changes
This transaction represents the sixth closing of an ongoing offering. The terms of the Preferred Stock and Warrants are identical to those issued in the five prior closings disclosed in previous 8-K filings between April and September 2016. The filing does not provide comparative financial data (revenue, profit, or cash flow) as it is a transactional report rather than a periodic financial statement.
Guidance, Outlook, and Risks
- Terms: Preferred Stock carries a 5.5% dividend and an initial conversion price of $4.50 per share. Series C-1 Warrants have an exercise price of $4.50, while Series C-2 Warrants have an exercise price of $7.75. Both have a five-year term.
- Registration Rights: The Company entered into a Registration Rights Agreement with the purchasers, substantially identical to prior agreements.
- Unregistered Sale: The securities were sold without registration under the Securities Act of 1933, relying on the Section 4(a)(2) exemption for transactions by an issuer not involving any public offering.
- Dilution Risk: The issuance of warrants to the placement agent includes full ratchet anti-dilution protection, which may impact future share counts.
Investor Verification Checklist
- Verify the total capital raised across all six closings of this offering to assess the full funding round size.
- Review the prior 8-K filings (April 14, May 4, June 6, July 7, and September 7, 2016) to confirm the cumulative number of Units issued.
- Assess the potential dilution impact of the 159,000 warrant shares and the 79,500 convertible shares relative to the current outstanding common stock.
- Confirm the Company's current cash position and burn rate to determine if the $357,750 proceeds are sufficient for near-term operations.